Return to frontpage
ExploreUnderstandIllumine

Anant Phadke

[email protected]

Anant Phadke, a medical graduate, has been a full-time volunteer since the 1978 for the cause of public healthcare and the People’s Health and Science Movement. He is the author of Drug Supply and Use (1995), by Sage, and the award-winning Marathi book, Healthcare for All? Yes it is possible!” which has been translated into two languages. An active member of collectives such as the All India Drug Action Network (AIDAN), LOCOST, Medico-Friend Circle, and Jan Aarogya Abhiyan (JSA), Dr. Phadke has contributed more than 100 and 300 articles in English and Marathi, respectively, on issues related to people’s science and health, especially on different aspects of India’s pharmaceutical policy.

image.jpg
Why Medicines are so Costly in India [HTML version]

India is a pharmaceutical paradox. It has earned for itself the name, “pharmacy of the world” as the third largest producer by volume, after China of

1.Policy Watch_20_front page.jpg
Why Medicines are so Costly in India

India is a pharmaceutical paradox. It has earned for itself the name, “pharmacy of the world” as the third largest producer by volume, after China of generic formulations, and a leading manufacturer of vaccines. In the international market, the low price and high quality of Indian generic formulations make them a good choice worldwide. Yet, at home, millions are pushed into poverty every year owing to expenses on healthcare, of which payment for medicines is a major component. In this article, Dr. Anant Phadke, a member of the All India Drug Action Network, which campaigns for affordable medicines, discusses the dynamics that direct these high prices such as marketing strategies by large pharmaceutical manufacturers, an incorrect price-regulatory framework, the plethora of irrational Fixed Dose Drug Combinations, and improper prescription practices by doctors. He draws attention to the fundamentally flawed Drug Price Control Order-2013, based on Market Based Pricing and argues for a policy of Cost Based Pricing of medicines. Dr. Phadke proposes generalisation of the well-established model of Tamil Nadu for procurement and supply of free medicines to patients in Public Health Facilities and its adoption in Kerala and Rajasthan, and argues for its replication in other States with suitable adaptations.Related Articles and ResourcesHTML VersionDownload PDF (484 KB)]